These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10888366)

  • 21. Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat.
    Hartung HP; Schäfer B; Fierz W; Heininger K; Toyka KV
    Neurosci Lett; 1987 Dec; 83(1-2):195-200. PubMed ID: 2450307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.
    Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka KV; Gold R; Strominger JL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13872-7. PubMed ID: 11717443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
    Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
    J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration.
    Pilartz M; Jess T; Indefrei D; Schröder JM
    Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
    Redford EJ; Smith KJ; Gregson NA; Davies M; Hughes P; Gearing AJ; Miller K; Hughes RA
    Brain; 1997 Oct; 120 ( Pt 10)():1895-905. PubMed ID: 9365379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses.
    Xiao J; Zhai H; Yao Y; Wang C; Jiang W; Zhang C; Simard AR; Zhang R; Hao J
    Neuroscience; 2014 Mar; 262():156-64. PubMed ID: 24412705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraneural activated T cells cause focal breakdown of the blood-nerve barrier.
    Spies JM; Westland KW; Bonner JG; Pollard JD
    Brain; 1995 Aug; 118 ( Pt 4)():857-68. PubMed ID: 7655884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens.
    Zhu W; Zhang K; Mix E; Wang X; Adem A; Zhu J
    J Neurosci Res; 2011 Mar; 89(3):448-56. PubMed ID: 21259331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Nennesmo I; Adem A; Zhu J
    Exp Neurol; 2004 Dec; 190(2):486-94. PubMed ID: 15530887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parthenolide inhibits the initiation of experimental autoimmune neuritis.
    Zhang M; Liu RT; Zhang P; Zhang N; Yang CL; Yue LT; Li XL; Liu Y; Li H; Du J; Duan RS
    J Neuroimmunol; 2017 Apr; 305():154-161. PubMed ID: 28284336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.
    Bai XF; Zhu J; Zhang GX; Kaponides G; Höjeberg B; van der Meide PH; Link H
    Clin Immunol Immunopathol; 1997 May; 83(2):117-26. PubMed ID: 9143372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfer of experimental allergic neuritis with P2-reactive T-cell lines.
    Rostami A; Burns JB; Brown MJ; Rosen J; Zweiman B; Lisak RP; Pleasure DE
    Cell Immunol; 1985 Apr; 91(2):354-61. PubMed ID: 2581699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis.
    Bao L; Lindgren JU; Zhu Yu; Ljunggren HG; Zhu J
    Neurobiol Dis; 2003 Feb; 12(1):73-81. PubMed ID: 12609491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase expression during experimental autoimmune neuritis.
    Hughes PM; Wells GM; Clements JM; Gearing AJ; Redford EJ; Davies M; Smith KJ; Hughes RA; Brown MC; Miller KM
    Brain; 1998 Mar; 121 ( Pt 3)():481-94. PubMed ID: 9549524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines.
    Heininger K; Stoll G; Linington C; Toyka KV; Wekerle H
    Ann Neurol; 1986 Jan; 19(1):44-9. PubMed ID: 2418761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6.
    Deretzi G; Pelidou S; Zou L; Quiding C; Mix E; Levi M; Wahren B; Zhu J
    Immunology; 1999 May; 97(1):69-76. PubMed ID: 10447716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
    Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
    Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.